Article

Rheumatology Network's Top 5: July 16, 2022

Author(s):

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending July 16, 2022.

Rheumatoid Arthritis Quiz: Cancer and RA

Cancer is linked to many chronic conditions, but what is its relationship with rheumatoid arthritis? Test your knowledge with this quiz.

Neutralizing Anti-Drug Antibodies Linked to Worse Disease Activity in Inflammatory Arthritis

Further research examining a possible association between smoking, which was found more frequently in nADAb-positive patients, is warranted.

Akiko Iwasaki, PhD: Exploring the Drivers of Lupus via Endogenous Retroviruses

Iwasaki and her team analyzed 3220 unique sequences of endogenous retroviruses that are a part of the human genetic make up or genome to understand if retroviruses cause or worsen this disease.

Q&A: Achieving Minimal Disease Activity in Patients with Recent-Onset Psoriatic Arthritis

In this Q&A, Rubén Queiro, MD, PhD, discussed the findings of his study that examined the variables associated with achieving minimal disease activity in patients with recent-onset psoriatic arthritis.

John K Botson MD, RPh, CCD: FDA Approval of Pegloticase Injection Plus Methotrexate for Gout Treatment

John K. Botson MD, RPh, CCD, weighs in on the recent FDA approval of pegloticase injection plus methotrexate for the treatment of uncontrolled gout.

Related Videos
The Evolving Use of Biologics for PsA Care, with Philip Mease, MD
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD
Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
© 2025 MJH Life Sciences

All rights reserved.